Compare MDGL & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | AVY |
|---|---|---|
| Founded | 2011 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.1B |
| IPO Year | N/A | N/A |
| Metric | MDGL | AVY |
|---|---|---|
| Price | $561.08 | $181.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $553.08 | $200.27 |
| AVG Volume (30 Days) | 317.0K | ★ 785.0K |
| Earning Date | 11-04-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | ★ 5.74 |
| EPS | N/A | ★ 8.81 |
| Revenue | $740,640,000.00 | ★ $8,770,000,000.00 |
| Revenue This Year | $436.04 | $2.45 |
| Revenue Next Year | $53.17 | $4.28 |
| P/E Ratio | ★ N/A | $20.73 |
| Revenue Growth | ★ 864.21 | 1.03 |
| 52 Week Low | $265.00 | $156.23 |
| 52 Week High | $605.00 | $198.39 |
| Indicator | MDGL | AVY |
|---|---|---|
| Relative Strength Index (RSI) | 55.21 | 63.07 |
| Support Level | $546.20 | $172.00 |
| Resistance Level | $589.67 | $183.85 |
| Average True Range (ATR) | 20.09 | 3.68 |
| MACD | -6.52 | 0.97 |
| Stochastic Oscillator | 24.57 | 87.88 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.